Shares of Agios Pharmaceuticals, Inc. AGIOrallied almost 10% on Apr 9 after speculations were rife that the company might be acquired by other big players in the pharma and biotech industry. This bullish sentiment around the stock among investors was mainly triggered following Novartis’ NVSyesterday’s announcement that it has inked a deal to acquire the U.
S. based clinical stage gene therapy company, AveXis, Inc AVXS.Agios Pharmaceuticals Shares Rise on Buyout Speculation
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться